Exact Sciences' shares rise 6.8% following CMS reimbursement decision, Modernizing Medicine closes gMed acquisition & more – 4 GI/endoscopy company key notes

Here are four recent news updates on gastroenterology and endoscopy companies.

Zacks Investment Research noted EndoChoice has been assigned a consensus broker rating score of 1.00 — strong buy — from the four brokers that provide coverage for the company.

Following CMS' decision to maintain Medicare reimbursement for Cologuard, Exact Sciences' shares rose 6.8 percent, according to a Journal Sentinel report.

Modernizing Medicine completed the previously announced acquisition of gMed.

The American Gastroenterological Association, Crohn's & Colitis Foundation of America and Janssen Biotech selected Theresa Alenghat, VMD, PhD as the inaugural winner of the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease Epigenetics Research.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast